Riluzole Augmentation in Treatment-Resistant Obsessive–Compulsive Disorder: An Open-Label Trial
- 1 September 2005
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 58 (5) , 424-428
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Riluzole Augmentation for Treatment-Resistant DepressionAmerican Journal of Psychiatry, 2004
- Treatment of obsessive‐compulsive disorder in patients who have comorbid major depressionJournal of Clinical Psychology, 2004
- Subtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major DepressionArchives of General Psychiatry, 2004
- Obsessive–Compulsive DisorderNew England Journal of Medicine, 2004
- An Open-Label Trial of Riluzole in Patients With Treatment-Resistant Major DepressionAmerican Journal of Psychiatry, 2004
- Comorbidity of Obsessive-Compulsive Disorder and DepressionThe Journal of Clinical Psychiatry, 2002
- Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette’s syndrome and obsessive–compulsive disorderBrain Research, 2000
- Effects of riluzole on electrically evoked neurotransmitter releaseBritish Journal of Pharmacology, 2000
- Energy on DemandScience, 1999
- Success and failure in the behavioral treatment of obsessive-compulsives.Journal of Consulting and Clinical Psychology, 1983